New AI-driven diagnostics target Parkinson's symptoms to help patients reclaim motor functions. Researchers use these tools to identify subtle biomarkers that human clinicians often miss. This shift enables more precise medication adjustments. While the clinical impact remains incremental, these AI tools provide a blueprint for treating other neurodegenerative diseases through personalized data analysis.